Recombinant DNA research; actions under guidelines; notice.
D026683:Advisory Committees; D026724:Ethical Review; D004989:Ethics; D035082:Federal Government; D015316:Genetic Therapy; D006076:Government; D033161:Government Regulation; D017408:Guidelines as Topic; D006805:Human Experimentation; D006801:Humans; D007153:Immunologic Deficiency Syndromes; D009316:National Institutes of Health (U.S.); D009369:Neoplasms; D011640:Public Policy; D012015:Reference Standards; D012107:Research Design; D012108:Research Personnel; D012926:Social Control, Formal; D014481:United States
Biomedical and Behavioral Research; Genetics and Reproduction; Human Gene Therapy Subcommittee; Legal Approach; NIH Guidelines; National Institutes of Health; Points to Consider: Transfer of Recombinant DNA into Human Subjects; Recombinant DNA Advisory Committee